Mackay Shields LLC’s Usana Health Sciences USNA Stock Holding History

Mackay Shields LLC’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,700	Closed	-$2.02M	–	1305
2021 Q1	$2.02M	Sell	20,700 -9,000	-30%	-$819K	0.01%	763
2020 Q4	$2.29M	Buy	29,700 +10,700	+56%	+$828K	0.02%	800
2020 Q3	$1.4M	Sell	19,000 -17,500	-48%	-$1.4M	0.01%	919
2020 Q2	$2.68M	Sell	36,500 -6,800	-16%	-$533K	0.02%	631
2020 Q1	$2.5M	Buy	+43,300	New	+$3.01M	0.02%	572
2019 Q1	–	Sell	-14,023	Closed	-$1.65M	–	1445
2018 Q4	$1.65M	Sell	14,023 -17,277	-55%	-$2M	0.01%	733
2018 Q3	$3.77M	Sell	31,300 -1,300	-4%	-$161K	0.03%	519
2018 Q2	$3.76M	Sell	32,600 -11,400	-26%	-$1.25M	0.03%	565
2018 Q1	$3.78M	Buy	+44,000	New	+$3.41M	0.02%	584

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Mackay Shields LLC's USNA Position: Q2 2021 in Review

Mackay Shields LLC sold out of Usana Health Sciences (USNA) in Q2 2021, closing a stake of 20,700 shares — an estimated $2.02M sold.

Mackay Shields LLC first reported a position in USNA in Q1 2018 and held it in 9 quarters. The position peaked at $3.78M in Q1 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

Mackay Shields LLC reported no remaining Usana Health Sciences position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 20,700 Usana Health Sciences shares in Q2 2021, an estimated $2.02M.
Mackay Shields LLC first reported a position in Usana Health Sciences in Q1 2018 and held it in 9 quarters.
Mackay Shields LLC's Usana Health Sciences position peaked at $3.78M in Q1 2018.
188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.